EHR Intervention to Increase HBOC Genetic Testing

Study acronym: ELISABETH
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Columbia University
305 trials monitored
See 27 trials at risk
Breast Cancer
5,455 trials monitored
See 306 trials at risk
Ovarian Cancer
1,341 trials monitored
See 94 trials at risk
The purpose of this research study is to test how well a new approach - using tools built into the electronic health record (EHR)- can help increase genetic testing for hereditary breast and ovarian cancer (HBOC) in women who have a family history that puts them at higher risk. The study will also look at what helps or gets in the way of using these tools in everyday clinical care. As part of this study, the investigators are also evaluating a website called RealRisks, which is designed to support patients in understanding their risk and making informed decisions about genetic testing. By studying how patients and primary care providers use this tool, the investigators hope to improve the way decision support tools are used to guide conversations and decisions about HBOC testing.
Trial Details
NCT Number NCT07876349
Lead Sponsor Columbia University
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Breast Cancer, Ovarian Cancer, Hereditary Cancer Syndrome
Related terms Breast Neoplasms, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov